Studies have demonstrated that activation of ALKBH7 in apoptosis-resistant cancer cells may contribute to enhancing the toxic effects of chemotherapeutic alkylating agents in tumors, suggesting a potential alternative pathway for tumor eradication. The gene discussed is ALKBH7; the disease is neoplasm.